All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

by Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Conte, P-F, Majois, F, Espie, M, Morand, M, Vaissiere, N, Villanova, G
Published 2009

Phase II study of lonidamine in metastatic breast cancer.

by Pronzato, P., Amoroso, D., Bertelli, G., Conte, P. F., Cusimano, M. P., Ciottoli, G. B., Gulisano, M., Lionetto, R., Rosso, R.
Published 1989

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Canc...

by Ardizzoni, A., Addamo, G. F., Baldini, E., Borghini, U., Portalone, L., De Marinis, F., Lionetto, R., Conte, P. F., Bruzzi, P., Pennucci, M. C.
Published 1995

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

by Bertolini, F, Malavasi, N, Scarabelli, L, Fiocchi, F, Bagni, B, Giovane, C Del, Colucci, G, Gerunda, G E, Depenni, R, Zironi, S, Fontana, A, Pettorelli, E, Luppi, G, Conte, P F
Published 2011

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

by Aabo, K., Adams, M., Adnitt, P., Alberts, D. S., Athanazziou, A., Barley, V., Bell, D. R., Bianchi, U., Bolis, G., Brady, M. F., Brodovsky, H. S., Bruckner, H., Buyse, M., Canetta, R., Chylak, V., Cohen, C. J., Colombo, N., Conte, P. F., Crowther, D., Edmonson, J. H., Gennatas, C., Gilbey, E., Gore, M., Guthrie, D., Yeap, B. Y.
Published 1998